New study demonstrates Xiidra's efficacy in alleviating discomfort in symptomatic contact lens wearers

Published on September 9, 2025
Xiidra is a prescription eye drop used to treat the signs and symptoms of dry eye disease (DED) and works by targeting the source of inflammation.
Continue reading on website
Other news

Real-World Study Shows Positive Pegcetacoplan Results for Geographic Atrophy

September 9, 2025
The study, published in American Journal of Ophthalmology, showed pegcetacoplan to be more effective than in the clinical trials. However, study participants experienced significant loss of BCVA and eyes with prior anti-VEGF treatment were more likely to develop exudation. Despite this, the researchers concluded pegcetacoplan to be “safe and effective” in the real-world setting. Photo: Paul Karpec

Topcon Healthcare Announces Investment in Senseye to Advance Mental Health Diagnostics Through Ocular Biomarkers

September 10, 2025
LA JOLLA, Calif.—Topcon Healthcare, Inc., a global leader in digital health and ocular data solutions, has announced a strategic investment in Senseye, Inc., a U.S.-based developer of a mental health diagnostic platform powered by ocular biomarkers, marking the company’s first investment in technology for mental health and neuropsychiatry. Leveraging the eye as a non-invasive window into the brain